Topera, a US-based medical device company for spotting heart problems, has raised $25m in its series C round from a consortium including an undisclosed “new strategic industry partner”.
The C round was led by venture capital firm New Enterprise Associates (NEA) and included existing investors and the company’s management team.
The money will be primarily used to support the planned commercial launch of the company’s RhythmView WorkStation and FirMap Catheter in Europe and the US this year.